发明名称 Pharmaceutical compositions and method for prophylaxis and therapy of radical-mediated cell damage
摘要 The method of prophylaxis and therapy of radical-mediated cell damage includes administering an effective amount of at least one steroid and at least one pharmaceutical adjuvant to a human being. The at least one steroid is selected from the group consisting of ent-estradiol, 17alpha-estradiol, 8-dehydro-estradiol, 8-dehydro-17alpha-estradiol, 8(14)-dehydroestradiol, 6,8-didehydro-17alpha-estradiol, 6-dehydroestriol, 9(11)-dehydroestriol, 20-hydroxymethyl-3-hydroxy-19-norpregna-1,3,5(10)-triene, 14alpha, 15alpha-methylene-8-dehydroestradiol, 14alpha, 15alpha-methylene-estradiol, 2-hydroxy-estradiol-3-methyl ether, 3-hydroxy-1,3,5(10)-estratriene-17S-spirooxirane, 3-hydroxy-1,3,5(10),9(11)-estratetraene-17S-spirooxirane, and 14beta,15beta-methylene-8-dehydroestradiol. This method strongly inhibits changes in cells and tissues, such as lipid peroxidation and oxidation of low-density lipoprotein (LDL) cholesterol, triggered by reaction oxygen species, free oxygen radicals and other forms of radicals and thus reduces attendant irreversible membrane and endothelial damage.
申请公布号 US6172056(B1) 申请公布日期 2001.01.09
申请号 US19960646341 申请日期 1996.05.09
申请人 JENAPHARM GMBH & CO. KG 发明人 DROESCHER PETER;MENZENBACH BERND;PONSOLD KURT;UNDEUTSCH BERND;OETTEL MICHAEL;ROEMER WOLFGANG;KAUFMANN GUENTER;SCHROEDER JENS
分类号 A61K31/565;A61K31/575;C07J1/00;(IPC1-7):A61K31/56 主分类号 A61K31/565
代理机构 代理人
主权项
地址